NMS Group S.p.A. is the largest company in Italy committed in innovation and oncology R&D.

With 420 total employees, NMS Group employs over 200 qualified researchers involved in research and development, from 'target validation'​ to phase II clinical trials.

NMS Group S.p.A. is the only company in Italy able to manage the entire integrated chain of the research and development path: from pre-clinical phase of research, to First-Time-In-Man of clinical phase, up to production and packaging of the finished drug.

The Group also provides services of Research and Production addressed to local and international markets through three different companies: Accelera, one of the few companies engaged in preclinical research in Italy; Clioss engaged in clinical development starting from First-Time-In-Man and Nerpharma, dealing with activities from formulation to production of the active principle.

Life Sciences

Pharmaceutical

Research

Therapeutics

NMS Group

Hugues Dolgos

Arianna Startari

Rosita Lupi

Enrico Girani

Tiziano Andreoli

The Business and Financial Operations team at NMS Group is responsible for overseeing the financial health and business strategy of the company. This includes financial planning, analysis, and control (Business Controller, Business Control Manager), driving business growth and market penetration (Business Development Manager), managing procurement processes (Buyer Ufficio Acquisti), and ensuring accurate financial reporting and compliance (Senior Accountant). Their work supports the Group's commitment to innovation and oncology research by providing the financial insights and strategies necessary to sustain and expand operations.

Business and Financial Operations

Science and Research Team

Business and Financial Operations

About

Team members

Other teams at NMS Group

Science and Research Team